Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Genitourinary 1Gastrointestinal 1

Conditions

Pancreatic Neoplasms 2Colorectal Neoplasms 2Stomach Neoplasms 1Small Cell Lung Carcinoma 1Prostatic Neoplasms 1Malnutrition 1Lung Neoplasms 1Esophageal Neoplasms 1Duodenal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Body Weight Changes 1

Interventions

pembrolizumab 36Magnetic Resonance Spectroscopy 23Gemcitabine 19Specimen Handling 15Nivolumab 12Carboplatin 12Surveys and Questionnaires 11Paclitaxel 11Cetuximab 11Early Intervention, Educational 10Bevacizumab 10Standard of Care 9Cyclophosphamide 9Cisplatin 9Radiosurgery 8Methods 8Fluorouracil 8Docetaxel 8Blood Specimen Collection 8Psychiatric Rehabilitation 7Pemetrexed 7sargramostim 6aldesleukin 6Taxes 6Injections 6Fluorodeoxyglucose F18 6Educational Status 6Drug Therapy 6Biopsy 6Albumin-Bound Paclitaxel 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lung Neoplasms × Nutrition Therapy × Gastrointestinal × Clear all
NCT00769652 2023-10-03

Medical Nutrition Therapy or Standard Care in Treating Patients With Lung Cancer, Pancreatic Cancer, or Stage III or Stage IV Prostate Cancer

Rutgers, The State University of New Jersey

Phase NA Terminated
8 enrolled 6 charts
GastrointestinalGenitourinaryThoracic

Body Weight Changes, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Malnutrition, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡